Pharmaceutical Technology Europe
Biotechnological developments have led to an increased number of recombinant proteins or antibodies in drug development that offer high potential in various diseases, such as cancer, growth disturbances and diabetes.
François Becher
Advertisement
Articles by François Becher
Advertisement
Latest Updated Articles
Bioanalysis of recombinant proteins by mass spectrometrySeptember 1st 2008
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Improving Oral Peptide Delivery Through Structural Modifications
2
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
3
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
4
PharmTech AI Pulse Check: AI Policies Become Regulators' Inspection Yardstick
5